Medical Cannabis for HIV: Symptoms, Evidence and Risks

52 minute read
0
(0)

Cannabis does not cure human immunodeficiency virus (HIV), has not been shown to lower viral load in people, and never replaces antiretroviral therapy (ART). It has mostly been studied for symptoms that can linger, such as poor appetite, nausea and nerve pain, with mixed results. Every form carries THC effects, so the decision belongs with you and your HIV doctor.

In short

Smoke and vapor Reach your airways and lungs. Joints, blunts, pipes, bongs, vapes and dabs all deliver hot smoke or aerosol through the same airways.
Any form, including edibles and tinctures THC effects, drowsiness and a higher chance of falls [1], plus the work of keeping your ART on schedule. What you swallow also passes through the liver, where some HIV medicines are processed.
Shared joints, pipes and vapes Do not pass HIV through saliva [2]. Other germs can still travel on a shared mouthpiece.

Bottom line: the form you use, and how it fits with your ART, is a conversation to have with your HIV doctor.

Start where you are

When ART works but symptoms stay: appetite, nerve pain, nausea and sleep

A suppressed viral load is a real win, and it does not always mean you feel well. With HIV medicine taken every day, many people keep the virus under control and live long, healthy lives [3]. Some of them still wake up every morning to symptoms that treatment alone has not settled:

  • Appetite and weight. Food loses its pull, and weight drifts down even when you try to eat.

  • Nerve pain in the feet and hands. Burning, tingling or numbness that makes walking and sleeping harder.

  • Nausea. An unsettled stomach that can make it harder to take pills on time.

  • Sleep. Nights that are short, broken or restless.

  • Anxiety and mood. Worry and low days that sit on top of everything else.

These symptoms rarely come one at a time. Poor appetite feeds weight loss, pain and poor sleep make each other worse, and nausea can push a dose later and later. Months can go by like this. Bringing up cannabis with a clinician can feel like one more risk when you already carry the weight of HIV stigma in waiting rooms.

You can have that conversation calmly and privately. A physician licensed in your state reviews your symptoms and current medicines with you one on one, all online, with no trip to an office. They tell you honestly whether medical cannabis fits your situation and your state’s program. No promises of relief, only a clear look at your options.

What is human immunodeficiency virus (HIV)?

Human immunodeficiency virus (HIV) is a virus that attacks the immune system. It targets CD4 cells, a type of white blood cell (T lymphocyte) that coordinates the body’s defense against infections. HIV is a retrovirus: it writes its own genetic material into the cell and turns the cell into a factory for new virus. Without treatment, HIV can lead to acquired immunodeficiency syndrome (AIDS) [4].

How HIV is transmitted — and how it isn’t

HIV spreads only through certain body fluids from a person who has HIV and a detectable viral load: blood, semen, pre-seminal fluid, rectal and vaginal fluids, and breast milk [2].

Spread through

  • Anal or vaginal sex without a condom or HIV prevention medicine
  • Sharing needles, syringes or other drug-injection equipment
  • Pregnancy, birth or breastfeeding, from parent to baby
  • Rarely, a needle-stick injury at work in health care

Not spread through

  • Saliva, sweat or tears
  • Kissing, hugging or shaking hands
  • Sharing toilets, dishes or drinks
  • Mosquitoes, ticks or other insects

Is there a cure for HIV?

Not yet. Antiretroviral therapy keeps the virus under control instead [3]. People who take HIV medicine as prescribed and reach and keep an undetectable viral load do not transmit HIV to sexual partners, often summed up as Undetectable = Untransmittable, or U=U [5].

From HIV to AIDS: the stages

Without treatment, HIV moves through three stages: acute infection in the first weeks, often with flu-like symptoms; chronic infection, which can last years with few symptoms; and AIDS, when the immune system is badly damaged [6]. Treatment can stop this progression.

HIV-1 and HIV-2

There are two main types. HIV-1 causes most infections around the world and in the United States. HIV-2 is less common, found mostly in West Africa, and tends to progress more slowly [7].

Life expectancy on treatment

Starting HIV medicine soon after diagnosis and taking it as prescribed lets people with HIV live long, healthy lives and protects their partners [3]. Staying in care is what keeps that outlook.

Medical coding: HIV disease is recorded as ICD-10-CM code B20; HIV infection without symptoms as Z21 [8].

Can HIV pass through a shared joint?

Could medical cannabis fit your life with HIV?

Thirteen short questions about your treatment, symptoms and medicines. You get a plain summary of what research says for a situation like yours and what to bring to the doctor who manages your HIV.

13 questions · about a minute · your answers stay in this browser

Question 1 of 13

Right now, do you have any of these: a high fever, new confusion, vomiting so bad you cannot keep fluids down, fast weight loss over a few weeks, or new weakness, numbness or trouble speaking?

These need your HIV care team or emergency care first, before anything else.

HIV cannot be transmitted through saliva: can you share a joint, pipe or vape?

You will not get or pass HIV by sharing a joint, pipe, bong or vape mouthpiece. HIV is not transmitted through saliva, the same reason kissing and sharing a drink are not a risk [2]. Edibles, tinctures and topicals involve no shared mouthpiece at all.

Low risk for HIV — not for other germs

A shared mouthpiece still swaps saliva, and saliva can carry other infections. If your immune system is weakened, that matters more. Using your own device is the simple fix.

Where cannabis does show up in HIV research is behavior. A 2025 systematic review of studies in Black sexually minoritized men found that using cannabis together with alcohol and other substances went along with more sex without a condom [9]. That is a link seen in observational studies, not proof that cannabis causes it. Still, it is a good reason to plan protection, such as condoms or PrEP (HIV prevention medicine), before a night out [10].

How cannabis acts in the body

How does cannabis interact with HIV and the immune system?

Cannabis works through your body’s own cannabinoid system: a set of receptors that THC and CBD from the plant attach to. Two of those receptors explain most of what researchers ask about in HIV.

How it works in general — not a treatment claim

  1. 1CB1 receptors: brain and nerves

    THC acts mainly here. That explains the effects people notice, like hunger, relaxation and drowsiness, and also slower reactions and coordination.

  2. 2CB2 receptors: immune cells

    CB2 sits on many immune cells. This is why researchers ask whether cannabis shifts inflammation or immune activity in people with HIV.

  3. 3What is seen only in the lab

    In cell and animal studies, THC changed how genes behave during SIV or HIV infection, in both directions [11]. That does not carry over to people automatically.

Viral load
Seen in people: Not shown to change HIV viral load.
Lab and animal only: In a study of 15 rhesus macaques infected with SIV, a monkey virus closely related to HIV, daily THC alongside ART changed small RNA markers in the blood [12].
Inflammation
Seen in people: In a preliminary snapshot study, marijuana use went along with lower CRP, a blood marker of inflammation, but only among people taking PrEP [13].
Lab and animal only: THC shifted gene activity in infected cells, with results pointing in opposite directions [11].
Cervical HPV in women with HIV
Seen in people: In a long-running cohort of women with and without HIV, marijuana use was not linked to cervical HPV infection or precancer [14].
Lab and animal only: No lab or animal data

For you, that means one thing: no study in people has shown that cannabis lowers HIV viral load or rebuilds the immune system. ART does that job.

Cannabis and the immune system

What does research say about cannabis and HIV?

Research on cannabis in people with HIV is real but uneven: the strongest studies describe risks such as falls, while the evidence on symptom relief is still observational and mixed. Some studies found a link, some found none, and some could not draw a conclusion. Below, each common claim is matched to the kind of data behind it, strongest first.

Strong designs first; “shown” is used only where they agree.

What you may have heard, and how strong the evidence is
ClaimType of dataHow strong
Cannabis use goes with more falls in people with HIV Meta-analysis pooling 12 studies with 54,513 people living with HIV; cannabis use was a significant risk factor for falls [1] Meta-analysis Consistent link, not proof of cause
Cannabis use disorder is common in HIV care Cohort of 10,652 adults enrolled in HIV care in the U.S. [15] Observational Large, but one point of view: who develops a problem, not why
Cannabis eases HIV symptoms Scoping review of 51 observational studies, 14 of them in HIV; no standard symptom scales or doses [16] Review No firm conclusion yet
Using cannabis with alcohol makes people skip next-day ART or PrEP Day-by-day cohort of Black sexual and gender minority adults [17] Observational No significant link found
Cannabis changes the virus itself In lab and animal studies only: SIV-infected monkeys and infected cells [12][11] Lab only Not tested in people

Key takeaway

For HIV symptoms, the data is still observational and pulls in different directions [16]. Dronabinol, a prescription form of THC, is a separate, FDA-approved medicine with its own label, covered further down.

Filter the studies on this page

Every study cited on this page is here. Pick a type to see how much of what you hear comes from people, and how much from a test tube.

  • 2024 · Meta-analysis

    What predicts falls in people living with HIV?

    12 studies, 54,513 people with HIV. Cannabis use stood out as an independent risk factor for falls [1].

  • 2025 · Scoping review

    Does cannabis help manage symptoms in HIV and cancer?

    51 observational studies, 14 of them in HIV. No firm conclusion: designs were mostly snapshots, without standard symptom measures or doses [16].

  • 2025 · Systematic review

    How is cannabis use tied to HIV outcomes in Black sexually minoritized men?

    Mixed findings. Using cannabis together with alcohol and other substances went along with more condomless sex [9].

  • 2017 · Cohort

    Who in HIV care is at risk of cannabis use disorder?

    10,652 adults in U.S. HIV care. Among people who used cannabis, 49% met criteria for cannabis use disorder; among 18- to 29-year-olds, 67% [15].

  • 2025 · Cohort

    Do people with HIV drink or smoke less when they use more cannabis?

    No. Using cannabis more often, or starting it, went along with more hazardous drinking and more cigarettes a day, not fewer [18].

  • 2026 · Cohort, day by day

    Does using cannabis and alcohol together affect next-day ART or PrEP doses?

    No significant link to next-day doses among Black sexual and gender minority adults [17].

  • 2010 · Cohort

    Is marijuana use tied to cervical HPV or precancer in women with HIV?

    Women with and without HIV were followed over time. Marijuana use was not associated with HPV infection or cervical precancer [14].

  • 2021 · Cohort

    How did marijuana use change for people with HIV during the COVID-19 pandemic?

    People with HIV were followed through the first pandemic year to see how their marijuana use changed and what went along with the change. Findings were mixed [19].

  • 2026 · Cross-sectional

    Is cannabis use linked to heart changes on an ECG in people with HIV?

    No clear difference in signs of a past heart attack or other ECG abnormalities between people who used cannabis and those who did not [20].

  • 2025 · Cross-sectional

    Does marijuana use change inflammation markers in people on PrEP?

    Preliminary: marijuana use went along with lower CRP, an inflammation marker, only among PrEP users [13].

  • 2023 · Animal study

    How do SIV, ART and THC change RNA markers in monkey blood?

    15 rhesus macaques. Infection, ART and THC each shifted small RNA markers in blood vesicles. In lab and animal studies only [12].

  • 2025 · Review of lab studies

    What does THC do to gene activity in SIV and HIV infection?

    Mixed: possible enhancement of infection in one cell type, possible suppression in immune cells called macrophages. In lab and animal studies only [11].

Which symptoms were studied

Which HIV symptoms has cannabis been studied for?

Cannabis has been studied in people with HIV mainly for appetite and weight, nerve pain, nausea, and sleep and mood. In every case the data comes from observational studies, and results are mixed [16]. What people say they use it for and what studies can confirm are not the same thing, so each card shows both.

  • Observational

    Appetite and weight loss

    What people report: eating more and holding on to weight are among the most common reasons people with HIV give for using cannabis.

    What studies show: studied, results mixed [16]. The prescription cannabinoid dronabinol is FDA-approved for appetite loss with weight loss in AIDS [21]. More on cannabis and appetite loss.

  • Observational

    HIV-related nerve pain

    What people report: relief from neuropathy, nerve damage that causes burning, tingling or numbness, usually in the feet and hands.

    What studies show: mostly surveys and snapshots, results mixed [16]. More on cannabis and chronic pain.

  • Observational

    Nausea

    What people report: a settled stomach, including nausea that comes with medicines.

    What studies show: studied, results mixed, with no standard doses or forms [16]. More on cannabis and nausea.

  • Observational

    Sleep and mood

    What people report: easier sleep and less stress or worry.

    What studies show: mixed [16], and cannabis use disorder, which can worsen both sleep and mood, is common in HIV care [15]. More on insomnia and anxiety.

THC and CBD are different compounds. A risk or effect found with THC does not automatically apply to a product with CBD only, and the reverse is true too. When you read about results, check which one was studied.

Does the form matter?

Does the way you use cannabis change the risks?

Partly. Some risks belong to one form, some to every form, and some only to sharing. Cannabis is not the same thing as smoking, so it helps to sort the risks into three layers.

  • Smoke and vapor

    Smoking burns plant material, and the smoke reaches your airways and lungs. Vaping and dabbing skip the burning, but a hot aerosol still travels the same path. This layer is about your throat and lungs.

  • Any form

    THC causes drowsiness and slower reactions however it enters your body, and cannabis use is linked with more falls in people with HIV [1]. Any form also has to fit around your ART schedule. What you swallow passes through the liver before reaching the blood.

  • Shared devices

    Sharing a joint, pipe or vape does not pass HIV, but it can pass other germs. See the section on saliva and sharing.

Forms of cannabis: what applies to each
FormHow it entersStarts and lastsApplies only to this formApplies to any form
Smoking: joints, blunts, pipes, bongsLungsWithin minutes; wears off soonerSmoke from burning plant material in the airways; shared mouthpiecesTHC effects, drowsiness, falls, keeping ART on time
Vaping and dabbingLungs, as heated aerosolWithin minutes; wears off soonerHot aerosol through the same airways; shared devicesTHC effects, drowsiness, falls, keeping ART on time
Edibles, drinks, capsulesSwallowed; through the gut and liverLater; lasts longerDelayed effect makes it easy to take too muchTHC effects, drowsiness, falls, keeping ART on time
Tinctures and sprays under the tongueLining of the mouth; some is swallowedVaries by productStrength differs from product to productTHC effects, drowsiness, falls, keeping ART on time
Topicals and patchesSkin; patches deliver into the bloodCreams act where applied; patches release slowlyCreams stay mostly local; patches do notTHC in a patch still reaches the blood
SuppositoriesRectal or vaginal liningVariesRarely used; little researchTHC effects, drowsiness, falls, keeping ART on time
FDA-approved prescriptions: dronabinol, nabiloneSwallowed capsule or liquidLater; lasts longerDose set by a prescriber; see the next sectionTHC effects, drowsiness, falls

Form is only half the picture. The other half is what is in the product: THC, CBD, or a mix of both in a set ratio. THC is the compound that causes the high, drowsiness and slower reactions; CBD does not cause a high. A product label tells you both amounts, and that ratio matters as much as the form when you talk it through with your doctor.

Dosage: what studies used

There is no standard cannabis dose for people with HIV. The observational studies on symptoms did not use standard doses, forms or symptom scales [16], so this page does not suggest one. Dosing is something to work out with a clinician who knows your full medicine list. For general background, read how medical cannabis dosing works.

Moderate risk: edibles act late

Swallowed cannabis takes longer to kick in than smoke or vapor and lasts longer. Taking another serving because the first “didn’t work” is a common way people end up with far more THC than they meant to [22].

Prescription cannabinoids are a separate thing

Dronabinol vs. medical marijuana: what’s the difference?

Dronabinol is a prescription medicine made of synthetic THC, approved by the FDA; medical marijuana is plant-based cannabis you buy from a state-licensed dispensary with a physician’s recommendation. They share THC, but almost everything else about them differs [21].

Prescription cannabinoids and medical card products side by side
AspectPrescription: dronabinol (Marinol, Syndros); nabilone (Cesamet)Medical card products
What it isSynthetic THC in a capsule (Marinol) or an oral liquid (Syndros); nabilone is a related synthetic cannabinoidPlant-based products such as flower, edibles, tinctures and topicals, made and sold under state rules
FDA-approved usesDronabinol: loss of appetite with weight loss in people with AIDS, and nausea and vomiting from chemotherapy. Nabilone: nausea and vomiting from chemotherapy [21]Not approved by the FDA for any condition [21]
How the dose is setBy the prescriber, with a fixed strength per capsule or milliliterWorked out with your clinician; product strength varies by product and state
How you get itA prescription filled at a pharmacyA physician’s recommendation plus registration in your state’s program
InsuranceMay be covered as a prescription drug, depending on your planGenerally paid out of pocket

If you already take dronabinol, or are curious about either route, bring both to the same appointment. Ask your HIV doctor whether a prescription cannabinoid makes sense for your symptom, and ask a physician who handles medical cannabis evaluations what your state’s program allows. Each should know about the other, so nobody doubles your THC by accident.

How a medical card evaluation works

Can you use cannabis while taking ART or PrEP?

Cannabis never replaces ART. If you use it in any form, tell the doctor who manages your HIV, and do not stop or change your regimen on your own. Some interactions are about drug levels in the blood, others about daily habits; open each card to see what is known and how strong the evidence is.

Boosted ART (ritonavir, cobicistat) and liver enzymes (CYP3A4)Drug-level

Ritonavir and cobicistat are “boosters” added to some HIV regimens. They slow down CYP3A4, a liver enzyme that also helps break down THC, so THC levels may run higher and effects may last longer. You can look up your exact regimen in the Liverpool HIV Drug Interactions checker [23], then go over the result with your HIV doctor or pharmacist.

Alcohol with cannabis and next-day ART or PrEP dosesClinical

In a day-by-day study of Black sexual and gender minority adults, using cannabis and alcohol together on one day was not significantly linked with missing ART or PrEP doses the next day [17]. Reassuring, but limited: one group of people, and use was self-reported.

Cannabis use disorder and staying on ARTClinical

Cannabis use disorder means use has become hard to control and is causing problems. It was common among cannabis users in a large U.S. HIV care cohort, and the authors flag it as a threat to taking ART consistently, calling for targeted screening and support [15].

Opioids and stimulantsClinical

In a cohort of women living with HIV in South Africa, stimulant use was linked with starting opioids later [24]. That is a link, not a cause, but combining several substances makes their effects harder to predict. Tell your care team about everything you take.

THC and ART in animal studiesLab

In SIV-infected monkeys, ART counteracted some infection-driven changes in blood RNA markers, and THC was studied alongside it [12]. This is from lab and animal studies only; do not apply it to your own treatment.

Questions to ask your HIV doctor

Bring these to your next visit. Writing the answers down makes the conversation with a medical cannabis physician easier too.

  1. Do any of my ART medicines, including boosters, interact with THC or CBD?
  2. Would THC, CBD or a mix make more sense for my symptom?
  3. Could a prescription cannabinoid such as dronabinol be an option for me?
  4. Given my age, balance and other medicines, what is my risk of falls?
  5. How do I make sure cannabis never gets in the way of taking my doses on time?

If you take PrEP to prevent HIV, the same rule applies: keep taking it as prescribed, and mention cannabis use at your PrEP visits [10].

Risks to know before you start

What are the risks of cannabis for people living with HIV?

The most reliable findings about cannabis in people with HIV are about risk, not relief: a link with falls, and a high rate of cannabis use disorder. Both come from large studies, and both are links seen in observational data rather than proof of cause.

What changed in people living with HIV who use cannabis?

Each row compares people with HIV who use cannabis with those who don’t. The dot is the best estimate, the bar is the likely range, and the gray line means no difference.

estimate · likely range (confidence interval) · no difference

Compared with people who don’t use cannabis

  • Falls 2.5× more often [1] (1.8–3.6)
  • Signs of a past heart attack on an ECG 1.0×, no clear difference [20] (0.8–1.3)
  • Other ECG changes 1.0×, no clear difference [20] (0.8–1.3)

Hazardous drinking when cannabis use changes

  • Using cannabis more often 2.0× more often [18] (1.7–2.4)
  • Starting cannabis 2.4× more often [18] (1.9–2.5)
Falls and hazardous drinking showed up more often among people with HIV who use cannabis, while heart findings on the ECG showed no clear difference. These are links from observational studies, not causes.
Show as a table
Effect sizes behind the chart (odds ratios with 95% confidence intervals) [1][20][18]
OutcomeCompared withOdds ratio (95% CI)Study
FallsPeople with HIV who don’t use cannabis2.54 (1.79–3.61)Meta-analysis, 2024 [1]
Signs of a past heart attack on an ECGPeople with HIV who don’t use cannabis1.02 (0.82–1.26)Cross-sectional, 2026 [20]
Other ECG abnormalitiesPeople with HIV who don’t use cannabis1.02 (0.80–1.32)Cross-sectional, 2026 [20]
Hazardous drinking, using cannabis more oftenNo increase in cannabis use2.02 (1.67–2.44)Cohort, 2025 [18]
Hazardous drinking, starting cannabisNo increase in cannabis use2.44 (1.88–2.52)Cohort, 2025 [18]

49% of people who used cannabis in a cohort of 10,652 adults in HIV care met criteria for cannabis use disorder [15].

Among 18- to 29-year-olds: 67% [15].

Cohort study, 10,652 people, 2017 [15]

Sedation, coordination and driving

Why falls? Researchers point to the way THC slows thinking, clouds judgment and affects coordination, even in people who do not notice a problem with their balance [1]. The same effects make driving or operating machinery unsafe after using cannabis. In people who inject drugs and often use several substances at once, memory and self-control were weaker in a 2025 cohort [25]; that group is not the same as most people with HIV, but it shows how mixing substances adds up.

Call your care team right away if…

  • You feel confused, panicky or not like yourself.

  • You fall and hurt yourself.

  • You have chest pain or a racing, pounding heartbeat.

  • You are vomiting and can’t keep fluids or your ART doses down.

Who should be careful with cannabis when living with HIV?

Some people with HIV face more risk from cannabis than others. If one of these describes you, raise it before you decide anything, and expect your doctor to ask about it.

  • Ages 18 to 29, or a past cannabis use disorder. In HIV care, 67% of cannabis users in this age group met criteria for the disorder [15].

  • Older adults and anyone who has fallen before. Cannabis use is tied to more falls in people with HIV [1].

  • Alcohol, opioids or stimulants on top of cannabis. More cannabis went with more hazardous drinking, and stimulants with starting opioids [18][24].

  • Pregnancy and breastfeeding. THC reaches the baby; health agencies advise against cannabis during this time [26].

  • Driving and operating machinery. THC slows reaction time and impairs driving [27].

  • A history of psychosis. Cannabis use is linked with psychosis and schizophrenia, especially in people at risk [26].

High risk: skipping or changing ART

Cannabis does not replace HIV treatment, and stopping or changing ART on your own lets the virus come back. If cannabis, nausea or anything else is making you miss doses, talk to your HIV doctor first.

What science doesn’t know yet about cannabis and HIV

The honest answer to “does cannabis help with HIV symptoms?” is: not yet known. Results are contradictory. Some studies found a link, some found none, and some could not reach a conclusion at all. These are the main limitations and evidence gaps that further research still has to close:

  • Mostly snapshots. Most studies capture one moment in time, so they show links but cannot establish cause [1].
  • No standard doses, forms or symptom scales. Studies measured symptoms and cannabis use in different ways, so results can’t be pooled [16].
  • Lab results on the virus disagree. Cell and animal studies point in opposite directions and do not carry over to people [11][12].
  • Narrow samples. Many studies drew on specific groups, such as mostly men or one health system, which limits who the findings apply to [15].
  • Use is self-reported. How much cannabis people used, and in what form, usually comes from their own recall [16].

Studies under way

New clinical trials on cannabis and HIV open and close every year. You can see which ones are currently recruiting, and where, on ClinicalTrials.gov [28].

So can you get a card?

Is HIV a qualifying condition for a medical marijuana card?

In many state medical cannabis programs, yes: HIV or AIDS is named directly on the list of qualifying conditions. The rules differ from state to state, and each state keeps its own list [29].

If HIV is not on your state’s list, you may still qualify through a related condition. Common ones are cachexia (severe wasting, meaning major loss of weight and muscle), chronic or nerve pain, persistent nausea and anxiety; read more on chronic pain, nausea and anxiety. Some states also let a physician recommend cannabis for a condition that is not on the list.

To get ready, have something that confirms your diagnosis, such as a clinic letter or lab record, and a current list of your medicines, including your ART regimen. Because laws differ so much, it is worth knowing your state’s cannabis laws before your appointment.

How to get a medical marijuana card with HIV

Getting a card takes four steps, and the first three happen online. Here is what each one involves and how long the parts we handle take.

  1. Step 1Fill out a short form

    Your state, your symptoms and your current medicines. It takes about five minutes.

  2. Step 2See a physician licensed in your state

    A one-on-one appointment of about fifteen minutes, all online. You agree on the time with the doctor; keep the hour around it free.

  3. Step 3Get your signed recommendation

    If you qualify, the signed recommendation usually arrives within 24–48 hours after the appointment.

  4. Step 4Register with your state program

    You apply to your state’s program. Review times and card delivery are set by the state agency, not by us.

What happens after you book

You get a confirmation email; if you don’t see it, check your spam folder. Your appointment details and documents live in your account. Whether you can visit a dispensary right after the appointment depends on your state, which is explained in the section on state programs.

Who sees your HIV status?

Your diagnosis is shared with the physician at your appointment, as part of your medical record. Health information like this is protected under HIPAA, the federal health privacy law [30]. What appears on the recommendation and in your state’s patient registry is set by state rules; you can ask the program what it records before you apply.

4.6out of 5 on Google

Across 250 reviews from patients in the states where we are licensed. We do not sort them by score and do not hide the low ones.

  • 150,000+patients evaluated — everyone who has been through an appointment with us, in every state where we are licensed
  • Since 2017doing only this: online evaluations for medical cannabis programs, and nothing else on the side

Questions about the process? See answers to common medical card questions. Veterans can read about support for veterans, and people on a limited income about low-income options.

Renewing your card or moving to another state

A medical cannabis card does not last forever: every state sets its own expiration date and renewal process, and most ask for a fresh physician’s recommendation before you renew [29]. Renewal usually looks like the first time around, a short form and an appointment with a physician licensed in your state.

Use the renewal appointment as a check-in. If your ART regimen, other medicines or symptoms have changed since last time, say so: a new booster or a new prescription can change what makes sense for you.

Moving changes more. A card belongs to the state that issued it, so a new state means a new program and a new recommendation. Some states accept out-of-state cards for visitors, with limits; see which states accept out-of-state medical marijuana cards. Lost your card? Here is what to do if your card was lost.

Set a reminder a month before your card expires

A month gives you time for the appointment and for the state to process your renewal, so you are not left without a valid card in between.

After approval: state programs, dispensaries and the medical vs. recreational difference

After the physician signs your recommendation, you register with your state’s medical cannabis program, which adds you to its patient registry and issues your card. Whether you can visit a dispensary right away, or have to wait for the state to approve you, depends on the state [29].

Medical patients buy from state-licensed dispensaries. In regulated programs, products are tracked and tested before sale, so you can ask to see the lab results for the batch you buy [29]. Prescription cannabinoids such as dronabinol are a different thing: they come from a pharmacy, not a dispensary (see the comparison above). Many state laws also let a registered caregiver buy and handle cannabis for a patient who cannot do it alone; those rules are part of each state’s program.

Taxes
With a medical card: Often lower; varies by state.
Recreational: Usually higher, often with added local taxes.
Purchase and possession limits
With a medical card: Often higher for registered patients; varies by state.
Recreational: Set for all adults; often lower.
Minimum age
With a medical card: Adult patients; minors only under special rules in some states.
Recreational: Adults only, at the state’s legal age.
Advice on form
With a medical card: You talk forms and products through with a physician.
Recreational: Store staff advice only.

For the numbers in your state, see medical vs. recreational cannabis taxes.

What to ask at the dispensary

  1. How much THC and CBD is in this product, and in what ratio?
  2. What form is it, and how is it taken?
  3. Can I see the lab test results for this batch?
  4. How soon does it start working, and how long does it last?

Traveling with medical cannabis

Cannabis and HIV: questions patients ask

About cannabis and HIV

Can cannabis help manage pain for people with HIV?

It depends. People with HIV often say they use cannabis for nerve pain, and studies have looked at it, but the evidence is observational and mixed [16]. It is not a proven pain treatment. If pain is your main symptom, ask your doctor which options, cannabis included, fit your medicines and your history.

Does cannabis affect HIV viral load or ART adherence?

No effect on viral load has been shown in people; findings about the virus come from lab and animal studies only [12]. Adherence is the bigger concern: cannabis use disorder, which is common in HIV care, can get in the way of taking ART on time [15]. Keep your doses on schedule whatever you decide.

Are there any specific risks of using cannabis if I have HIV?

Yes. The clearest are more falls [1] and a high rate of cannabis use disorder, especially in younger adults [15]. Drowsiness, slower reactions, more hazardous drinking [18] and possible interactions with boosted ART regimens [23] matter too. Smoke and vapor add airway irritation that edibles and tinctures avoid.

Can CBD be helpful for people with HIV?

It depends, and little is known. CBD does not cause a high, and THC’s risks don’t automatically apply to it. But the HIV studies on this page mostly looked at cannabis in general or THC, so CBD alone has not been shown to ease HIV symptoms. CBD can also interact with medicines, so check with your HIV doctor or pharmacist first [23].

Is it safe to use cannabis if I am on PrEP?

It depends on you. PrEP works best when you take it as prescribed [10]. In one day-by-day study, using cannabis with alcohol was not significantly linked with missed next-day PrEP doses [17]. Cannabis combined with alcohol and other substances has been linked with more condomless sex [9], so keep PrEP and protection in your plan.

Should I tell my HIV doctor about my cannabis use?

Yes. Your HIV doctor needs the full picture: THC can interact with some ART regimens [23], and cannabis use disorder can affect how consistently you take your medicine [15]. What you tell your doctor is protected health information under HIPAA [30]. Mention every form you use, including edibles, tinctures and CBD.

What are the most concerning substance use interactions with HIV treatment?

Combinations, mostly. Using cannabis more often went along with more hazardous drinking and more smoking [18], stimulant use with starting opioids [24], and mixing substances with weaker memory and self-control [25]. Each of these can make it harder to take ART on time. Tell your care team about everything you use.

Can cannabis help with mental health issues in people with HIV?

It depends, and caution is needed. Some people report less stress or better sleep, but the research is observational and mixed [16]. Cannabis use disorder is common in HIV care [15], and cannabis is linked with psychosis in people at risk [26]. Talk through mood or anxiety symptoms with your doctor before trying cannabis.

What are the key takeaways from research on cannabis and HIV?

Cannabis does not treat HIV and does not replace ART. The strongest findings are about risks: more falls [1] and common cannabis use disorder [15]. Evidence on symptom relief is observational and mixed [16], and effects on the virus come from lab and animal studies only. Decide together with your HIV doctor.

Does cannabis cure HIV?

No. There is no cure for HIV yet, and cannabis has not been shown to lower viral load or repair the immune system in people. HIV medicine is what keeps the virus under control [3]. Cannabis has only been studied as a possible help for some symptoms, alongside ART and never instead of it.

Do edibles or tinctures avoid the risks of smoking?

Partly. Edibles, tinctures and capsules skip the smoke and hot vapor that reach your lungs, and there is no shared mouthpiece. They do not skip THC’s effects: drowsiness, slower reactions and falls [1]. Edibles also start later and last longer, which makes it easy to take too much [22]. Choosing a form is a conversation with your doctor.

Is delta-8 THC the same as medical cannabis?

No. Delta-8 THC products are usually made from hemp and sold outside state medical programs, often without the testing licensed dispensaries require. The FDA has not approved them and has warned about their safety and labeling [32]. If you are weighing cannabis for HIV symptoms, a medical program and a physician’s guidance give you more to go on.

About the card

Do I need records of my HIV diagnosis?

It helps. Bring something that confirms your diagnosis, such as a clinic letter, a lab report or a visit summary, along with your current medicine list. Requirements differ by state: some programs ask for records, others let the physician rely on your history and what you share at the appointment. Your diagnosis stays protected health information [30].

I got a recommendation — can I go to a dispensary right away?

It depends on your state. In some states you can shop soon after you register; in others you wait until the state approves your application and issues your card. Review times are set by the state agency [29]. Check your state’s program before you plan a dispensary visit.

Who will see my diagnosis?

Your physician sees it at the appointment, as part of your medical record protected under HIPAA [30]. Your state program receives what its rules require for registration, and that differs by state. Dispensaries typically check your card or registration, not your medical records. If privacy worries you, ask your state program what it records.

Can I use my card in another state?

Sometimes. Some states accept out-of-state medical cards, often with limits, and many do not. Rules change, so check before you travel; this list of states that accept out-of-state cards is a good start. Taking cannabis across state lines is still against federal law.

What if I lose my card?

Contact your state program to request a replacement; most programs have a set process for it. Your recommendation and documents stay in your account. Step-by-step help is in what to do if your card was lost.

How long after the appointment do I get my recommendation?

Usually within 24–48 hours after the appointment, if the physician finds that you qualify. The appointment itself is telemedicine: a legal way to see a physician licensed in your state without an office visit, which state medical cannabis programs widely allow [29]. State registration then takes its own time.

All card questions

HIV support resources and research news

Medical cannabis is one small piece of living well with HIV. These free services cover the bigger pieces: testing, treatment, support and research.

  • Testing and treatment

    Find free, fast and confidential HIV testing near you with the CDC Get Tested locator [33], and HIV care, housing and support services with the HIV.gov HIV Services Locator [34].

  • Helplines and support

    CDC-INFO answers questions about HIV at (800) 232-4636 [35]. If cannabis or other substance use is getting hard to manage, the SAMHSA National Helpline is free and confidential at (800) 662-4357 [36].

  • Clinical trials

    Studies on HIV, including ones on cannabis and symptoms, list where and whom they are recruiting on ClinicalTrials.gov [28]. Ask your HIV doctor before you join one.

  • Latest cannabis news

    Law changes, new research and program updates, gathered in one place: cannabis news.

Other conditions people ask about

Symptoms that come with HIV often have their own pages. Each one follows the same approach: what the research shows, what it doesn’t, and how to talk it through with a doctor.

Full list of conditions

How else can we help you?

If you have read this far, you already know more than most people who ask about cannabis and HIV. Three things to carry with you:

  • Symptom support, not a cureCannabis has been studied for appetite, nausea, nerve pain and sleep, with mixed results. It does not treat HIV itself.
  • ART comes firstWhatever you decide, keep taking your HIV medicine on schedule. Cannabis never replaces it.
  • Decide with your HIV doctorYour medicines, your history and your state’s rules all shape the answer, so make it together.

Talk to a physician about your situation

About five minutes online for the form · about fifteen minutes with the doctor.

Your diagnosis is shared only with the physician at your appointment, as part of your protected medical record.

Trouble with the form? Call (888) 409-2951 or email [email protected]

Share your experience

Leave an anonymous messageTell us what this page failed to answer, or where we got something wrong. It goes to the team, not onto the page, and no account or email is needed.
Share your storyA longer account of living with this condition, written for the people who arrive at this page next. Published with your first name, or anonymously if you ask.
Write a public commentAsk a question, correct us, or answer somebody else’s question at the foot of this page. Comments are public once they clear moderation.Add a comment

    💬

    How else can we help you?

    Tell us what you’d like to see, learn, or get from us next.

    🕶️
    100% anonymous — share what’s on your mind
    We will only use it if we need to follow up on your message.

      💬

      Share Your Story with the Dr. Weedy Community

      Your positive, negative, or neutral experience can really help others. Feel free to share it in a few clear, short sentences.

      🕶️
      Your contact details are encrypted and will never be shared publicly

      References

      36 sources
      1. 1. Ibeneme SC, Odoh E, Martins N, et al. Developing an HIV-specific falls risk prediction model with a novel clinical index: a systematic review and meta-analysis method. BMC Infect Dis · 2024 · meta_analysis DOI: 10.1186/s12879-024-10141-5 PMID: 39696054
      2. 2. Centers for Disease Control and Prevention. How HIV Spreads. 2024.
      3. 3. HIVinfo, National Institutes of Health. HIV Treatment: The Basics. 2024.
      4. 4. Centers for Disease Control and Prevention. About HIV. 2024.
      5. 5. HIV.gov. Viral Suppression and an Undetectable Viral Load. 2024.
      6. 6. HIVinfo, National Institutes of Health. The Stages of HIV Infection. 2024.
      7. 7. HIVinfo, National Institutes of Health. HIV-2 (glossary). 2024.
      8. 8. Centers for Disease Control and Prevention, National Center for Health Statistics. ICD-10-CM Browser Tool. 2026.
      9. 9. Knox J, Magana C, Duncan DT, et al. Cannabis use and HIV among Black sexually minoritized men: a systematic review and narrative analysis. AIDS · 2025 · systematic_review DOI: 10.1097/QAD.0000000000004149 PMID: 39918441
      10. 10. HIV.gov. Pre-Exposure Prophylaxis (PrEP). 2024.
      11. 11. Valizadeh A, Veenhuis RT, Bradley BA, et al. Transcriptomic Alterations Induced by Tetrahydrocannabinol in SIV/HIV Infection: A Systematic Review. Int J Mol Sci · 2025 · systematic_review DOI: 10.3390/ijms26062598 PMID: 40141240
      12. 12. Kopcho S, McDew-White M, Naushad W, et al. Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ-THC). Viruses · 2023 · preclinical DOI: 10.3390/v15030623 PMID: 36992332
      13. 13. Morgan E, McDade TW, Manning W, et al. Assessing Inflammatory Biomarkers at the Intersection of Marijuana and PrEP Use: Preliminary Findings From the NCHAT-BIO Study. J Acquir Immune Defic Syndr · 2025 · cross_sectional DOI: 10.1097/QAI.0000000000003759 PMID: 40905335
      14. 14. D’Souza G, Palefsky JM, Zhong Y, et al. Marijuana use is not associated with cervical human papillomavirus natural history or cervical neoplasia in HIV-seropositive or HIV-seronegative women. Cancer Epidemiol Biomarkers Prev · 2010 · cohort DOI: 10.1158/1055-9965.EPI-09-1053 PMID: 20160270
      15. 15. Hartzler B, Carlini BH, Newville H, et al. Identifying HIV care enrollees at-risk for cannabis use disorder. AIDS Care · 2017 · cohort DOI: 10.1080/09540121.2016.1271393 PMID: 28006972
      16. 16. Cho H, Kalina E, Wu J, et al. A Scoping Review of Observational Research on Cannabis Use for Symptom Management in HIV and Cancer: Implications for Cannabis Nursing. J Clin Nurs · 2025 · systematic_review DOI: 10.1111/jocn.17565 PMID: 39603980
      17. 17. Chen YT, Knox J, Almirol E, et al. Cannabis and Alcohol Co-Use And HIV Biomedical Intervention Engagement Among Black Sexual/Gender Minority People: A Day-Level Analysis. Am J Prev Med · 2026 · cohort DOI: 10.1016/j.amepre.2025.108144 PMID: 41067548
      18. 18. Whitney BM, Delaney JAC, Drumright LN, et al. Brief report: Are changes in cannabis use frequency associated with changes in alcohol use and smoking among people with HIV (PWH) – A substitution question. Drug Alcohol Depend · 2025 · cohort DOI: 10.1016/j.drugalcdep.2025.112958 PMID: 41260023
      19. 19. Wang Y, Ibañez GE, Vaddiparti K, et al. Change in marijuana use and its associated factors among persons living with HIV (PLWH) during the COVID-19 pandemic: Findings from a prospective cohort. Drug Alcohol Depend · 2021 · cohort DOI: 10.1016/j.drugalcdep.2021.108770 PMID: 34049094
      20. 20. Larson ME, Pan Y, Lakhani F, et al. The Association Between Cannabis Use and Electrocardiographic Abnormalities in People Living With HIV. J Acquir Immune Defic Syndr · 2026 · cross_sectional DOI: 10.1097/QAI.0000000000003786 PMID: 41129190
      21. 21. U.S. Food and Drug Administration. FDA and Cannabis: Research and Drug Approval Process. 2024.
      22. 22. Centers for Disease Control and Prevention. About Cannabis. 2024.
      23. 23. University of Liverpool. HIV Drug Interactions Checker. 2026.
      24. 24. Schluth CG, Rosen JG, Mcingana M, et al. Longitudinal patterns and predictors of opioid and stimulant use initiation and cessation among female sex workers living with HIV in South Africa. Drug Alcohol Depend · 2025 · cohort DOI: 10.1016/j.drugalcdep.2025.112593 PMID: 39952169
      25. 25. Lalanne L, Kirchherr S, Audran M, et al. Episodic memory and inhibitory control in people who inject substances results of cohort COSINUS study. BMC Psychiatry · 2025 · cohort DOI: 10.1186/s12888-025-07223-2 PMID: 40898189
      26. 26. Centers for Disease Control and Prevention. Cannabis Health Effects. 2024.
      27. 27. National Highway Traffic Safety Administration. Drug-Impaired Driving. 2024.
      28. 28. U.S. National Library of Medicine. ClinicalTrials.gov: HIV and cannabis studies. 2026.
      29. 29. National Conference of State Legislatures. State Medical Cannabis Laws. 2025.
      30. 30. U.S. Department of Health and Human Services. Health Information Privacy: Your Rights Under HIPAA. 2024.
      31. 31. Bureau of Alcohol, Tobacco, Firearms and Explosives. ATF Form 4473 — Firearms Transaction Record. 2024.
      32. 32. U.S. Food and Drug Administration. 5 Things to Know about Delta-8 Tetrahydrocannabinol. 2024.
      33. 33. Centers for Disease Control and Prevention. Get Tested: National HIV, STD and Hepatitis Testing. 2026.
      34. 34. HIV.gov. HIV Services Locator. 2026.
      35. 35. Centers for Disease Control and Prevention. CDC-INFO. 2026.
      36. 36. Substance Abuse and Mental Health Services Administration. SAMHSA’s National Helpline. 2026.
      0 Comments
      Inline Feedbacks
      View all comments
      Security check required

      Our security system needs to verify your connection. Please reload the page and complete the quick verification — your details are safe and nothing was lost.